Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunostimulants--therapeutic aspects].

W Diezel1, H D Volk, V Daniel

  • 1Klinik und Poliklinik für Hautkrankheiten, Humboldt-Universität zu Berlin.

Archiv Fur Geschwulstforschung
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personalized risk prediction of postoperative cognitive impairment - rationale for the EU-funded BioCog project.

European psychiatry : the journal of the Association of European Psychiatrists·2018
Same author

The basis of autoimmunity in MRL-lpr/lpr mice and man.

Immunology today·2014
Same author

Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

A NOVel ELISPOT assay to quantify HLA-specific B cells in HLA-immunized individuals.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Effects of remifentanil and fentanyl on the cell-mediated immune response in patients undergoing elective coronary artery bypass graft surgery.

The Journal of international medical research·2008
Same author

Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial.

Neuroscience·2008
Same journal

Dietary fructose enhances the development of atypical acinar cell nodules in the pancreas of rats pretreated with N-nitrosomorpholine.

Archiv fur Geschwulstforschung·1990
Same journal

[The influence of macrophages on the leukemogenic activity of Rauscher murine leukemia virus].

Archiv fur Geschwulstforschung·1990
Same journal

Transfection by DNA-nuclear protein HMG1 complexes: raising of efficiency and role of DNA topology.

Archiv fur Geschwulstforschung·1990
Same journal

[Attempts at analyzing the initiation of the initial processes of carcinogenesis based on the Xiphophorus melanoma model].

Archiv fur Geschwulstforschung·1990
Same journal

Primary prevention of cancer: priorities for practical implementation and research.

Archiv fur Geschwulstforschung·1990
Same journal

Role of environmental factors in cancer etiology.

Archiv fur Geschwulstforschung·1990
See all related articles

Immunostimulatory agents like Interleukin-2 and Interferon-gamma show promise for treating immunodeficiency and cancer. Further research into their mechanisms and applications is ongoing for future therapeutic use.

Area of Science:

  • Immunology and Pharmacology
  • Biochemistry

Context:

  • Review of current knowledge on immunostimulatory agents.
  • Focus on agents with potential therapeutic applications.

Purpose:

  • To survey the known mechanisms of action for various immunostimulatory agents.
  • To outline the therapeutic applications of these agents in clinical settings.

Summary:

  • Discusses Interleukin-2, Interferon-gamma, Tumor Necrosis Factor, Thymosin alpha 1, Thymopentin, Splenopentin, Thymulin, Thymostimulin, Muramyl dipeptide, Bestatin, Tuftsin, and Levamisole.
  • Details their respective modes of action and current or potential therapeutic uses.
  • Highlights the potential for treating immunodeficiency disorders and cancer.

Impact:

Related Experiment Videos

  • Provides a consolidated overview of key immunostimulatory agents.
  • Informs future research directions for developing novel immunotherapies.
  • Suggests the near-term possibility of using these agents in clinical practice for cancer and immunodeficiency treatment.